The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a novel granulocyte scoring system for use as a predictive/prognostic biomarker in patients with advanced melanoma undergoing treatment with combination immunotherapy.
 
Max Julve
No Relationships to Disclose
 
Yien Ning Sophia Wong
No Relationships to Disclose
 
Margarita Diez de los Rios Riobo
Honoraria - Ipsen; MSD
Travel, Accommodations, Expenses - Pfizer; Pierre Fabre
 
Yago Garitaonaindia
Travel, Accommodations, Expenses - Pfizer
 
Diana I. Rosero
Speakers' Bureau - LEO Pharma
Travel, Accommodations, Expenses - Servier
 
Jazmine Needham
No Relationships to Disclose
 
Juan Jose Soto
Travel, Accommodations, Expenses - Eisai; Pfizer; Seagen
 
Chloe Beland
No Relationships to Disclose
 
Ha Mo Linh Le
No Relationships to Disclose
 
James Larkin
Honoraria - Agence Unik; Bristol-Myers Squibb; Cambridge Healthcare research; Eisai; Incyte; Merck Serono; Novartis; Pfizer; RCGP; Royal College of Physicians; touchEXPERTS; touchIME; VJOncology
Consulting or Advisory Role - Agence Unik; Apple Tree Partners; Aptitude Health; AstraZeneca; Bristol-Myers Squibb; Calithera Biosciences; Debiopharm Group; eCancer; Eisai; EUSA Pharma; GlaxoSmithKline; Goldman Sachs; Incyte; Insel Gruppe; iOnctura; Ipsen; Merck Serono; MSD Oncology; Novartis; Pfizer; Philogen; Pierre Fabre; Roche; Syncona; Telix Pharmaceuticals; Ultimovacs
Research Funding - Achilles Therapeutics (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Immunocore (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Roche; ESMO; GlaxoSmithKline; immatics; Pierre Fabre; Roche/Genentech
 
Andrew J.S. Furness
Consulting or Advisory Role - Achilles Therapeutics; GlaxoSmithKline; Immunocore; Neogene Therapeutics
Speakers' Bureau - Bristol Myers Squibb Foundation; Eisai; Ipsen; Merck; Pfizer
Patents, Royalties, Other Intellectual Property - WO2019008375A1 (co-inventor of methods of identifying responders to cancer treatment)
Travel, Accommodations, Expenses - Achilles Therapeutics; Adaptimmune; ESMO; Iovance Biotherapeutics